@article{GroebnerWorstWeischenfeldtetal.2018,
  author    = {Gr{\"o}bner, Susanne N. and Worst, Barbara C. and Weischenfeldt, Joachim and Buchhalter, Ivo and Kleinheinz, Kortine and Rudneva, Vasilisa A. and Johann, Pascal D. and Balasubramanian, Gnana Prakash and Segura-Wang, Maia and Brabetz, Sebastian and Bender, Sebastian and Hutter, Barbara and Sturm, Dominik and Pfaff, Elke and H{\"u}bschmann, Daniel and Zipprich, Gideon and Heinold, Michael and Eils, J{\"u}rgen and Lawerenz, Christian and Erkek, Serap and Lambo, Sander and Waszak, Sebastian and Blattmann, Claudia and Borkhardt, Arndt and Kuhlen, Michaela and Eggert, Angelika and Fulda, Simone and Gessler, Manfred and Wegert, Jenny and Kappler, Roland and Baumhoer, Daniel and Stefan, Burdach and Kirschner-Schwabe, Renate and Kontny, Udo and Kulozik, Andreas E. and Lohmann, Dietmar and Hettmer, Simone and Eckert, Cornelia and Bielack, Stefan and Nathrath, Michaela and Niemeyer, Charlotte and Richter, G{\"u}nther H. and Schulte, Johannes and Siebert, Reiner and Westermann, Frank and Molenaar, Jan J. and Vassal, Gilles and Witt, Hendrik and Burkhardt, Birgit and Kratz, Christian P. and Witt, Olaf and van Tilburg, Cornelis M. and Kramm, Christof M. and Fleischhack, Gudrun and Dirksen, Uta and Rutkowski, Stefan and Fr{\"u}hwald, Michael and Hoff, Katja von and Wolf, Stephan and Klingebeil, Thomas and Koscielniak, Ewa and Landgraf, Pablo and Koster, Jan and Resnick, Adam C. and Zhang, Jinghui and Liu, Yanling and Zhou, Xin and Waanders, Angela J. and Zwijnenburg, Danny A. and Raman, Pichai and Brors, Benedikt and Weber, Ursula D. and Northcott, Paul A. and Pajtler, Kristian W. and Kool, Marcel and Piro, Rosario M. and Korbel, Jan O. and Schlesner, Matthias and Eils, Roland and Jones, David T. W. and Lichter, Peter and Chavez, Lukas and Zapatka, Marc and Pfister, Stefan M.},
  title     = {The landscape of genomic alterations across childhood cancers},
  series = {Nature},
  volume    = {555},
  journal   = {Nature},
  organization    = {ICGC PedBrain-Seq Project, ICGC MMML-Seq Project,},
  doi       = {10.1038/nature25480},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-229579},
  pages     = {321-327},
  year      = {2018},
  abstract  = {Pan-cancer analyses that examine commonalities and differences among various cancer types have emerged as a powerful way to obtain novel insights into cancer biology. Here we present a comprehensive analysis of genetic alterations in a pan-cancer cohort including 961 tumours from children, adolescents, and young adults, comprising 24 distinct molecular types of cancer. Using a standardized workflow, we identified marked differences in terms of mutation frequency and significantly mutated genes in comparison to previously analysed adult cancers. Genetic alterations in 149 putative cancer driver genes separate the tumours into two classes: small mutation and structural/copy-number variant (correlating with germline variants). Structural variants, hyperdiploidy, and chromothripsis are linked to TP53 mutation status and mutational signatures. Our data suggest that 7-8\% of the children in this cohort carry an unambiguous predisposing germline variant and that nearly 50\% of paediatric neoplasms harbour a potentially druggable event, which is highly relevant for the design of future clinical trials.},
  language  = {en}
}
@article{WeibelBasseLuesebrinkHessetal.2013,
  author    = {Weibel, Stephanie and Basse-Luesebrink, Thomas Christian and Hess, Michael and Hofmann, Elisabeth and Seubert, Carolin and Langbein-Laugwitz, Johanna and Gentschev, Ivaylo and Sturm, Volker J{\"o}rg Friedrich and Ye, Yuxiang and Kampf, Thomas and Jakob, Peter Michael and Szalay, Aladar A.},
  title     = {Imaging of Intratumoral Inflammation during Oncolytic Virotherapy of Tumors by \(^{19}\)F-Magnetic Resonance Imaging (MRI)},
  series = {PLoS ONE},
  volume    = {8},
  journal   = {PLoS ONE},
  number    = {3},
  doi       = {10.1371/journal.pone.0056317},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-130311},
  pages     = {e56317},
  year      = {2013},
  abstract  = {Background Oncolytic virotherapy of tumors is an up-coming, promising therapeutic modality of cancer therapy. Unfortunately, non-invasive techniques to evaluate the inflammatory host response to treatment are rare. Here, we evaluate \(^{19}\)F magnetic resonance imaging (MRI) which enables the non-invasive visualization of inflammatory processes in pathological conditions by the use of perfluorocarbon nanoemulsions (PFC) for monitoring of oncolytic virotherapy. Methodology/Principal Findings The Vaccinia virus strain GLV-1h68 was used as an oncolytic agent for the treatment of different tumor models. Systemic application of PFC emulsions followed by \(^1H\)/\(^{19}\)F MRI of mock-infected and GLV-1h68-infected tumor-bearing mice revealed a significant accumulation of the \(^{19}\)F signal in the tumor rim of virus-treated mice. Histological examination of tumors confirmed a similar spatial distribution of the \(^{19}\)F signal hot spots and \(CD68^+\)-macrophages. Thereby, the \(CD68^+\)-macrophages encapsulate the GFP-positive viral infection foci. In multiple tumor models, we specifically visualized early inflammatory cell recruitment in Vaccinia virus colonized tumors. Furthermore, we documented that the \(^{19}\)F signal correlated with the extent of viral spreading within tumors. Conclusions/Significance These results suggest \(^{19}\)F MRI as a non-invasive methodology to document the tumor-associated host immune response as well as the extent of intratumoral viral replication. Thus, \(^{19}\)F MRI represents a new platform to non-invasively investigate the role of the host immune response for therapeutic outcome of oncolytic virotherapy and individual patient response.},
  language  = {en}
}
@phdthesis{Sturm2006,
  author    = {Sturm, Christian},
  title     = {Theoretical Investigation of the Geometrical Arrangements of alpha-alanyl-peptide Nucleic Acid Hexamer Dimers and the Underlying Interstrand Binding Motifs},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-20363},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2006},
  abstract  = {Die Funktionalit{\"a}ten der DNA oder RNA werden haupts{\"a}chlich durch die verschiedenen Wechselwirkungen der paarenden Nucleinbasen bestimmt. Um die komplexen Zusammenh{\"a}nge dieser verschiedenen Wechselwirkungen zu verstehen, werden Modellsysteme ben{\"o}tigt, die weniger Restriktionen durch das R{\"u}ckgrat besitzen. Ein Beispiel f{\"u}r solche Systeme sind Peptidnucleins{\"a}uren (PNA), in denen das Zuckerphosphatr{\"u}ckgrat der DNA oder RNA durch ein Peptidr{\"u}ckgrat ersetzt wird. Diederichsen et al. gelang es, eine große Anzahl solcher Systeme mit einen alpha-Alanyl-R{\"u}ckgrat zu synthetisieren, an das kanonische und nicht-kanonische Nucleins{\"a}uren gebunden sind. Diese Systeme aggregieren in verschiedenen Bindungsmotiven, die nicht in der DNA oder RNA auftauchen. Diese ungew{\"o}hnlichen Paarungsmotive k{\"o}nnten einen tiefen Einblick in das Zusammenspiel der Wechselwirkungen der Nucleinbasen geben, aber die geringen L{\"o}slichkeit der alpha-Alanyl-PNA Oligomere verhinderte eine experimentelle Charakterisierung der geometrischen Anordnung durch R{\"o}ntgenstruktur- oder NMR-Experimente. Lediglich die absolute Stabilit{\"a}t der verschiedenen Aggregate konnte durch Messungen der Schmelztemperatur mit Hilfe der UV-Spektroskopie bestimmt werden. Da die Kenntnis der geometrischen Strukturen sowie der ausgebildeten Bindungsmotive wichtig ist, um einen Einblick in das Zusammenspiel der einzelnen Wechselwirkungen zu erlangen, besteht das Ziel der vorliegenden Arbeit darin, solche Informationen mit der Hilfe von theoretischen Methoden zu erlangen. Zus{\"a}tzlich sind Effekte von Interesse, aus denen sich Trends bez{\"u}glich der Stabilit{\"a}t bestimmen lassen. Solche Untersuchungen sind einfacher zu realisieren als die Berechnung der absoluten Stabilit{\"a}ten, da viele Beitr{\"a}ge zur absoluten Energie f{\"u}r {\"a}hnliche Systeme (entropische und dynamische Effekte) in etwa gleich groß sind. Somit sind diese entropischen und dynamischen Effekte f{\"u}r das Ziel dieser Arbeit weniger wichtig. Zur Untersuchung der Bindungseigenschaften und der Stabilit{\"a}ten von alpha-Alanyl-PNA Oligomeren war es notwendig, bis dato nicht parametrisierte Nucleinbasen in den Parametersatz des Amber4.1 Kraftfelds zu integrieren. Die fehlenden Ladungen wurden durch Berechungen mit dem R.E.D-Programm-Paket ermittelt. Das Programm bestimmt aus dem elektrostatischen Potential einer optimierten Struktur die atomzentrierten Ladungen. Die fehlenden Bindungsparameter wurden der Literatur entnommen. Die Untersuchungen der einzelnen Dimere begannen jeweils mit der Konstruktion der alpha-Alanyl-PNAs f{\"u}r alle m{\"o}glichen Paarungsmodi. Es konnte gezeigt werden, dass bestimmte Paarungsmodi aufgrund der geometrischen Gegebenheiten der Dimere und des R{\"u}ckgrats nicht realisierbar waren. F{\"u}r andere Dimere war ein Aufbau der alpha-Alanyl-PNA-Dimere zwar m{\"o}glich, jedoch zerfielen die Dimere wieder w{\"a}hrend einer ersten Geometrieoptimierung aufgrund der hohen Spannung im R{\"u}ckgrat. Die stabilen Systeme wurden zun{\"a}chst in verschiedenen Molekulardynamik-(MD)-L{\"a}ufen simuliert. Informationen {\"u}ber die Geometrie bei T=0 K wurden durch Geometrieoptimierungen erhalten, die an verschieden Punkten der MD L{\"a}ufe gestartet wurden. Die resultierenden Geometrien aus den verschiedenen Anfangspunkten waren identisch. F{\"u}r die geometrieoptimierten Strukturen wurden f{\"u}r das T=0 K Modell die Wechselwirkungsenergien zwischen den Nucleinbasen und der Einfluss der R{\"u}ckgrats auf die Stabilit{\"a}t der Dimer in zwei separaten Schritten bestimmt. Im ersten Schritt wurde das R{\"u}ckgrat entfernt und die Schnittstellen mit Methylgruppen abges{\"a}ttigt. Die Wechselwirkungsenergie zwischen den Nucleinbasen wurde durch die Differenz der Energien des gesamten Systems und der Summe der Energien der einzelnen Nucleinbasen in der Geometrie des Dimers bestimmt. Aufgrund der durchgef{\"u}hrten Untersuchungen und die sich daraus ergebenen Korrelation der berechneten Stabilisierungsenergien mit der Schmelztemperatur konnte gezeigt werden, dass mit der vorgeschlagenen Methode eine verl{\"a}ssliche Beschreibung der PNA Systeme m{\"o}glich ist. F{\"u}r eine weitere Verbesserung des vorgestellten Modells bedarf es zus{\"a}tzliche R{\"o}ntgenstruktur- oder NMR-Experimente, die zur Strukturaufkl{\"a}rung der alpha-Alanyl-PNA Dimere entscheidend beitragen. Weitere detaillierte Daten {\"u}ber die Enthalpiebeitr{\"a}ge zur absoluten Energie der verschiedenen Komplexe w{\"a}ren sehr hilfreich, um die vorgestellte Methode zu best{\"a}tigen und zu verbessern. Diese Informationen k{\"o}nnten zum einen durch die Auswertung der Form der Schmelzkurve sowie durch Mikrokalorimetrie erhalten werden. F{\"u}r den Fall, dass die Vorhersagen durch die experimentellen Befunde best{\"a}tigt w{\"u}rden, k{\"o}nnte der Ansatz auf verwandte Systeme wie zum Beispiel beta-Alanyl-PNA, DNA oder RNA angewandt werden. Durch diese weiteren Informationen k{\"o}nnte unser Ansatz zus{\"a}tzlich durch die Ber{\"u}cksichtigung von dynamischen und/oder entropischen Effekte erweitert werden.},
  subject      = {Peptid-Nucleins{\"a}uren},
  language  = {en}
}
@article{SepahiFaustSturmetal.2019,
  author    = {Sepahi, Ilnaz and Faust, Ulrike and Sturm, Marc and Bosse, Kristin and Kehrer, Martin and Heinrich, Tilman and Grundman-Hauser, Kathrin and Bauer, Peter and Ossowski, Stephan and Susak, Hana and Varon, Raymonda and Schr{\"o}ck, Evelin and Niederacher, Dieter and Auber, Bernd and Sutter, Christian and Arnold, Norbert and Hahnen, Eric and Dworniczak, Bernd and Wang-Gorke, Shan and Gehrig, Andrea and Weber, Bernhard H. F. and Engel, Christoph and Lemke, Johannes R. and Hartkopf, Andreas and Huu Phuc, Nguyen and Riess, Olaf and Schroeder, Christopher},
  title     = {Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women},
  series = {BMC Cancer},
  volume    = {19},
  journal   = {BMC Cancer},
  doi       = {10.1186/s12885-019-5946-0},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-237676},
  year      = {2019},
  abstract  = {Background Inherited pathogenic variants in BRCA1 and BRCA2 are the most common causes of hereditary breast and ovarian cancer (HBOC). The risk of developing breast cancer by age 80 in women carrying a BRCA1 pathogenic variant is 72\%. The lifetime risk varies between families and even within affected individuals of the same family. The cause of this variability is largely unknown, but it is hypothesized that additional genetic factors contribute to differences in age at onset (AAO). Here we investigated whether truncating and rare missense variants in genes of different DNA-repair pathways contribute to this phenomenon. Methods We used extreme phenotype sampling to recruit 133 BRCA1-positive patients with either early breast cancer onset, below 35 (early AAO cohort) or cancer-free by age 60 (controls). Next Generation Sequencing (NGS) was used to screen for variants in 311 genes involved in different DNA-repair pathways. Results Patients with an early AAO (73 women) had developed breast cancer at a median age of 27 years (interquartile range (IQR); 25.00-27.00 years). A total of 3703 variants were detected in all patients and 43 of those (1.2\%) were truncating variants. The truncating variants were found in 26 women of the early AAO group (35.6\%; 95\%-CI 24.7 - 47.7\%) compared to 16 women of controls (26.7\%; 95\%-CI 16.1 to 39.7\%). When adjusted for environmental factors and family history, the odds ratio indicated an increased breast cancer risk for those carrying an additional truncating DNA-repair variant to BRCA1 mutation (OR: 3.1; 95\%-CI 0.92 to 11.5; p-value = 0.07), although it did not reach the conventionally acceptable significance level of 0.05. Conclusions To our knowledge this is the first time that the combined effect of truncating variants in DNA-repair genes on AAO in patients with hereditary breast cancer is investigated. Our results indicate that co-occurring truncating variants might be associated with an earlier onset of breast cancer in BRCA1-positive patients. Larger cohorts are needed to confirm these results.},
  language  = {en}
}
@article{DennerJennichesLangetal.2016,
  author    = {Denner, Ansgar and Jenniches, Laura and Lang, Jean-Nicolas and Sturm, Christian},
  title     = {Gauge-independent (MS)over-bar renormalization in the 2HDM},
  series = {Journal of High Energy Physics},
  volume    = {09},
  journal   = {Journal of High Energy Physics},
  number    = {115},
  doi       = {10.1007/JHEP09(2016)115},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-166402},
  year      = {2016},
  abstract  = {We present a consistent renormalization scheme for the CP-conserving Two-Higgs-Doublet Model based on (MS)over-bar renormalization of the mixing angles and the soft-Z 2-symmetry-breaking scale M sb in the Higgs sector. This scheme requires to treat tadpoles fully consistently in all steps of the calculation in order to provide gauge-independent S-matrix elements. We show how bare physical parameters have to be defined and verify the gauge independence of physical quantities by explicit calculations in a general R ξ -gauge. The procedure is straightforward and applicable to other models with extended Higgs sectors. In contrast to the proposed scheme, the (MS)over-bar renormalization of the mixing angles combined with popular on-shell renormalization schemes gives rise to gauge-dependent results already at the one-loop level. We present explicit results for electroweak NLO corrections to selected processes in the appropriately renormalized Two-Higgs-Doublet Model and in particular discuss their scale dependence.},
  language  = {en}
}
@article{AdolfBraunFussetal.2020,
  author    = {Adolf, Christian and Braun, Leah T. and Fuss, Carmina T. and Hahner, Stefanie and K{\"u}nzel, Heike and Handgriff, Laura and Sturm, Lisa and Heinrich, Daniel A. and Schneider, Holger and Bidlingmaier, Martin and Reincke, Martin},
  title     = {Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism},
  series = {Endocrine},
  volume    = {69},
  journal   = {Endocrine},
  number    = {3},
  issn      = {1355-008X},
  doi       = {10.1007/s12020-020-02348-8},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-315966},
  pages     = {625-633},
  year      = {2020},
  abstract  = {Context Primary aldosteronism (PA) is the most frequent form of endocrine hypertension. Besides its deleterious impact on cardiovascular target organ damage, PA is considered to cause osteoporosis. Patients and methods We assessed bone turnover in a subset of 36 postmenopausal women with PA. 18 patients had unilateral PA and were treated by adrenalectomy, whereas 18 patients had bilateral PA and received mineralocorticoid receptor antagonist (MRA) therapy respectively. 18 age- and BMI-matched females served as controls. To estimate bone remodeling, we measured the bone turnover markers intact procollagen 1 N-terminal propeptide, bone alkaline phosphatase, osteocalcin and tartrate resistant acid phosphatase 5b in plasma by chemiluminescent immunoassays at time of diagnosis and one year after initiation of treatment. Study design Observational longitudinal cohort study. Setting Tertiary care hospital. Results Compared with controls, patients with PA had mildly elevated osteocalcin at baseline (p = 0.013), while the other bone markers were comparable between both groups. There were no differences between the unilateral and the bilateral PA subgroup. One year after initiation of MRA treatment with spironolactone bone resorption and bone formation markers had significantly decreased in patients with bilateral PA. In contrast, patients adrenalectomized because of unilateral PA showed no significant change of bone turnover markers. Conclusion This study shows that aldosterone excess in postmenopausal women with PA is not associated with a relevant increase of bone turnover markers at baseline. However, we observed a significant decrease of bone markers in patients treated with spironolactone, but not in patients treated by adrenalectomy.},
  language  = {en}
}